Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$1.8M
2 rounds on record
Latest round
$1.8M
Venture round · Apr 2018 · 8 yr ago
Grants
$2.3M
1 grant · CORDIS
Backers
3
Plug and Play, Rev1 Ventures
The money's age
Long since its last round
101 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 23, 2018 Raised a round Venture round $1.8M · SEC Form D 2017 Founded
Funding rounds
RoundDateAmountInvestorsSource
Grant Aug 2019 $2.3M — CORDIS
Venture round Apr 2018 $1.8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Scioto Biosciences, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Mark HeimanExecutive OfficerSEC Form D
Joseph TrebleyExecutive Officer, DirectorSEC Form D
James SchulzExecutive Officer, DirectorSEC Form D
Kevin MeyerExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
AMILISeries A $10.5M · 4 yr ago • Founded 2019
AMILI runs Southeast Asia's first gut microbiome bank and offers microbiome testing and therapeutic research. Its data addresses the…
Kanvas Biosciences has developed cutting-edge imaging technology to map the microbiome and develop therapeutics.
Discover your unique microbiome with InnerBuddies' Microbiome Test. Improve your gut health with personalised advice tailored to your…
BiomEditVenture round $16M · 18 mo ago • Founded 2022 • 11-50 employees
About Us BiomEdit is an innovator in microbiome research. Our mission is to create products that raise the bar for animal health. Setting a…
OutpostPre-Seed $3.5M · 7 mo ago • Founded 2019 • 11-50 employees
Outpost builds AI models of the human microbiome so drug, food, and ingredient R&D teams can predict microbiome interactions and flag risks…
BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial…

Overview

Scioto Biosciences is a preclinical stage biotech company dedicated to innovative research and discovery in the field of microbiome therapeutics.

People

Mark Heiman
Executive Officer
Joseph Trebley
Executive Officer, Director
James Schulz
Executive Officer, Director
Kevin Meyer
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Indianapolis United States
HQ
We Are Optimizing Microbiome Delivery.
9800 Crosspoint Blvd, Indianapolis, IN 46256
company site

Financials

Total raised
$4.1M
Latest round
Grant
Funding rounds
2
Funding rounds
Round Announced Amount
Grant 2019 $2.3M Details
Venture - Series Unknown 2018 $1.8M Details